Mer­ck-part­nered an­ti­body mak­er read­ies $300M IPO as HKEX picks up pace

Three weeks af­ter In­no­Care launched its IPO in­to the wel­com­ing em­brace of HKEX in­vestors, Ake­so­bio is look­ing to one-up the com­pa­ny with its own …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.